Oxford University Press

SHERPA: Yellow

People

  1. Drilon
    Drilon
  2. Motzer
    Motzer
  3. Mellinghoff
    Mellinghoff
  4. Shuman
    Shuman
  5. Rosenblum
    Rosenblum
  6. Dunkel
    Dunkel
  7. Karajannis
    Karajannis
  8. Saltz
    Saltz
  9. Souweidane
    Souweidane
  10. Panageas
    Panageas

Groups

  1. Department of Medicine (1995)
  2. Solid Tumor Oncology Division (1624)
  3. GSK Faculty (765)
  4. Survivorship Research (639)
  5. Population Sciences Research Program (615)
  6. Epidemiology and Biostatistics (465)
  7. Department of Pathology and Laboratory Medicine (415)
  8. Gastrointestinal Oncology Service (386)
  9. Genitourinary Oncology Service (367)
  10. Tow Center for Developmental Oncology (TCDO) (352)
Search Within
Formats
  1. Journal Article (2131)
  2. Meeting Abstract (2072)
  3. Book Section (192)
  4. Review (92)
  5. Editorial (84)
  6. Guidelines (36)
  7. Correspondence (26)
  8. Book Whole (18)
  9. Conference Paper (15)
  10. Research Letter (10)
Groups
  1. Department of Medicine (1995)
  2. Solid Tumor Oncology Division (1624)
  3. GSK Faculty (765)
  4. Survivorship Research (639)
  5. Population Sciences Research Program (615)
  6. Epidemiology and Biostatistics (465)

More Groups

People
  1. Lisa De Angelis (119)
  2. Alexander Drilon (108)
  3. Robert Motzer (96)
  4. Ingo Mellinghoff (93)
  5. Stewart Shuman (88)
  6. Marc Rosenblum (87)

More People

Years
  1. 2025 (129)
  2. 2024 (304)
  3. 2023 (320)
  4. 2022 (331)
  5. 2021 (323)
  6. 2020 (325)

More Years

Publications
  1. Annals of Oncology (1670)
  2. Neuro-Oncology (855)
  3. JNCI: Journal of the National Cancer Institute (492)
  4. Nucleic Acids Research (210)
  5. Clinical Infectious Diseases (140)
  6. American Journal of Clinical Pathology (106)

More Publications

Results (4676)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Weight loss, physical and psychological patient reported outcomes (PROs) among obese patients (pts) with early breast cancer (BC)
    Meeting Abstract

    Di Meglio, A.; El-Mouhebb, M.; Michiels, S.; Jones, L.; Martin, E.; Matias, M.; Palhares, A. E. L.; Joly, F.; Vanlemmens, L.; Everhard, S.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Physical activity (PA) and patterns of quality of life (QOL) after adjuvant chemotherapy (CT) for breast cancer (BC)
    Meeting Abstract

    Di Meglio, A.; El-Mouhebb, M.; Michiels, S.; Carene, D.; Everhard, S.; Martin, A. L.; Cottu, P. H.; Lerebours, F.; Coutant, C.; Lesur, A.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • REVEAL: A phase I/II, open-label, multicenter, dose escalation and dose expansion study of NKTR-262 [TLR 7/8 agonist] plus NKTR-214 [CD122-biased agonist] with or without nivolumab (nivo) in patients (pts) with locally advanced or metastatic solid tumor malignancies
    Meeting Abstract

    Diab, A.; Marcondes, M.; Tagliaferri, M. A.; Hoch, U.; Zhang, J.; Rubas, W.; Kivimae, S.; Zalevsky, J.; Conley, A. P.; Borazanci, E.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Translational endpoints in patients with metastatic microsatellite-stable colorectal cancer (MSS-CRC) treated with durvalumab plus monalizumab (anti-NKG2A)
    Meeting Abstract

    Diamond, J. R.; Standifer, N.; Ascierto, M. L.; Morehouse, C.; Ghadially, H.; Canales, J. R.; Rebelatto, M. C.; Naidoo, J.; Mazzarella, L.; Patel, S.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Responder analysis based on patient-reported outcomes (PROs) and clinical endpoints (CEPs) in patients (pts) with metastatic Merkel cell carcinoma (mMCC) treated with avelumab
    Meeting Abstract

    D'Angelo, S. P.; Fofana, F.; Schlichting, M.; Henry-Szatkowski, M.; Hennessy, M.; Bharmal, M.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Molecular characterization of epithelioid sarcoma (ES) tumors derived from patients enrolled in a phase II study of tazemetostat (NCT02601950)
    Meeting Abstract

    Daigle, S.; Stacchiotti, S.; Schöffski, P.; Villalobos, V.; Cote, G.; Chugh, R.; Chen, T. W. W.; Jahan, T.; Loggers, E. T.; Italiano, A.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Causal modeling of CALGB/SWOG 80405 (Alliance) identifies primary (1°) side-related angiogenic drivers of metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Das, R. K.; Furchtgott, L.; Ou, F. S.; Swanson, D.; Hayete, B.; Harms, B.; Cunha, D.; Latourelle, J.; Wuest, D.; Khalil, I.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • AZD8186, a potent and selective inhibitor of PI3Kβ/δ, as monotherapy and in combination with abiraterone acetate plus prednisone (AAP), in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC)
    Meeting Abstract

    de Bono, J. S.; Hansen, A.; Choudhury, A. D.; Cook, N.; Heath, E. I.; Higano, C.; Linch, M.; Martin-Liberal, J.; Rathkopf, D. E.; Wisinski, K. B.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Preliminary results of PROCLAIM-CX-072: The first-in-human, dose-finding trial of PD-L1 probody therapeutic CX-072 as monotherapy in patients (pts) with advanced solid tumors
    Meeting Abstract

    Boni, V.; Garcia-Corbacho, J.; Ott, P. A.; Cho, D. C.; Autio, K. A.; Uboha, N.; Spira, A. I.; Humphrey, R.; Will, M.; Naing, A.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • ABP-100: A tetravalent bispecific T-cell engaging antibody for HER2+ solid tumors
    Meeting Abstract

    Boudot, A.; Huang, X.; Murphy, S.; Appleman, V.; Xu, H.; Cheung, N. K.; Macbeath, G.
    Annals of Oncology (2018)

    Fulltext@MSK | Save